Overexpression of SOX2 in tumors has been correlated with increased tumor thickness and invasion, metastasis in esophageal cancer, drug resistance, and decreased survival in tumors such as breast cancer and lung adenocarcinoma (26, 37). Here, SOX2 is linked to lung adenocarcinoma.